Safety assessment of spine MRI in deep brain stimulation patients.

B1+rms = root-mean-square value of the MRI effective component of the radiofrequency magnetic (B1) field C-spine = cervical spine DBS = deep brain stimulation IPG = implantable pulse generator L-spine = lumbar spine PD = Parkinson’s disease RF = radiofrequency SAR = specific absorption rate T-spine = thoracic spine T1W = T1-weighted T2W = T2-weighted deep brain stimulation diagnostic technique functional neurosurgery implants magnetic resonance imaging neurostimulator safety spine

Journal

Journal of neurosurgery. Spine
ISSN: 1547-5646
Titre abrégé: J Neurosurg Spine
Pays: United States
ID NLM: 101223545

Informations de publication

Date de publication:
14 Feb 2020
Historique:
received: 16 10 2019
accepted: 06 12 2019
entrez: 15 2 2020
pubmed: 15 2 2020
medline: 15 2 2020
Statut: aheadofprint

Résumé

Many centers are hesitant to perform clinically indicated MRI in patients who have undergone deep brain stimulation (DBS). Highly restrictive guidelines prohibit the use of most routine clinical MRI protocols in these patients. The authors' goals were to assess the safety of spine MRI in patients with implanted DBS devices, first through phantom model testing and subsequently through validation in a DBS patient cohort. A phantom was used to assess DBS device heating during 1.5-T spine MRI. To establish a safe spine protocol, routinely used clinical sequences deemed unsafe (a rise in temperature > 2°C) were modified to decrease the rise in temperature. This safe phantom-based protocol was then used to prospectively run 67 spine MRI sequences in 9 DBS participants requiring clinical imaging. The primary outcome was acute adverse effects; secondary outcomes included long-term adverse clinical effects, acute findings on brain MRI, and device impedance stability. The increases in temperature were highest when scanning the cervical spine and lowest when scanning the lumbar spine. A temperature rise < 2°C was achieved when 3D sequences were modified to 2D and when the number of slices was decreased by the minimum amount compared to routine spine MRI protocols (but there were still more slices than allowed by vendor guidelines). Following spine MRI, no acute or long-term adverse effects or acute findings on brain MR images were detected. Device impedances remained stable. Patients with DBS devices may safely undergo spine MRI with a fewer number of slices compared to those used in routine clinical protocols. Safety data acquisition may allow protocols outside vendor guidelines with a maximized number of slices, reducing the need for radiologist supervision.Clinical trial registration no.: NCT03753945 (ClinicalTrials.gov).

Identifiants

pubmed: 32059193
doi: 10.3171/2019.12.SPINE191241
pii: 2019.12.SPINE191241
doi:
pii:

Banques de données

ClinicalTrials.gov
['NCT03753945']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Auteurs

Alexandre Boutet (A)

1Joint Department of Medical Imaging, University of Toronto.
2University Health Network, Toronto.

Gavin J B Elias (GJB)

2University Health Network, Toronto.

Robert Gramer (R)

2University Health Network, Toronto.

Clemens Neudorfer (C)

2University Health Network, Toronto.

Jürgen Germann (J)

2University Health Network, Toronto.

Asma Naheed (A)

1Joint Department of Medical Imaging, University of Toronto.

Nicole Bennett (N)

1Joint Department of Medical Imaging, University of Toronto.

Bryan Li (B)

2University Health Network, Toronto.

Dave Gwun (D)

2University Health Network, Toronto.

Clement T Chow (CT)

2University Health Network, Toronto.

Ricardo Maciel (R)

2University Health Network, Toronto.
3Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto.

Alejandro Valencia (A)

2University Health Network, Toronto.

Alfonso Fasano (A)

3Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto.
4Krembil Brain Institute, Toronto.

Renato P Munhoz (RP)

3Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Division of Neurology, University of Toronto.
4Krembil Brain Institute, Toronto.

Warren Foltz (W)

5Department of Radiation Oncology, STTARR Innovation Centre, University Health Network, Toronto, Ontario, Canada; and.

David Mikulis (D)

1Joint Department of Medical Imaging, University of Toronto.
2University Health Network, Toronto.
4Krembil Brain Institute, Toronto.

Ileana Hancu (I)

6National Institutes of Health, Center for Scientific Review, Bethesda, Maryland.

Suneil K Kalia (SK)

2University Health Network, Toronto.

Mojgan Hodaie (M)

2University Health Network, Toronto.

Walter Kucharczyk (W)

1Joint Department of Medical Imaging, University of Toronto.
2University Health Network, Toronto.

Andres M Lozano (AM)

2University Health Network, Toronto.

Classifications MeSH